Ecstasy vs Molly: What's Actually in Pressed Pills

“Ecstasy” means pressed pills. “Molly” means powder or crystal. Neither term tells you what’s actually in the substance you’re holding. Both forms are frequently adulterated — and in some markets, powder is cut more often than pills, not less. The terminology matters for one reason: pills have a fixed dose per tablet (which can be tested), while powder requires weighing. But neither word is a purity guarantee, and assuming otherwise is one of the most common mistakes people make before taking MDMA.

Quick answers

What’s the difference between ecstasy and molly? Ecstasy refers to MDMA pressed into tablet form; molly refers to powder or crystal MDMA. Both are supposed to be MDMA. Neither form is inherently purer.

Is molly purer than ecstasy? No — and drug checking data proves it. DanceSafe and DrugsData.org have analyzed thousands of samples across both forms. Powder is often more adulterated because it is easier to cut: no pressing process, no logo, no pill-press consistency check.

What do pressed pills actually contain? Sometimes MDMA, sometimes nothing close to it. A 25-year analysis of EcstasyData/DrugsData samples found 199 unique adulterants in alleged MDMA samples, and more than half of submitted samples were misrepresented in some way (PMID 39437494).

How much MDMA is in a typical pill? Anywhere from zero to over 300 mg. Pills in the US have historically ranged from 80–120 mg when MDMA-containing; European “superpills” now routinely exceed 200 mg, with some flagged above 300 mg.

Can you test a pressed pill for fentanyl? Yes. Dissolve a small amount of the pill in water and use a fentanyl test strip. See the full fentanyl test strip guide for the MDMA-specific dilution protocol.

Ecstasy vs molly at a glance

What “ecstasy” and “molly” actually mean

The vocabulary split between ecstasy and molly became common in the US around 2008. The working assumption was that “molly” (short for molecular) signaled pure MDMA, while pills were more likely to be cut. That assumption has never been supported by testing data.

Palamar and colleagues (Substance Abuse, 2016) documented that “molly” is marketed as pure MDMA despite being frequently adulterated with synthetic cathinones and other novel psychoactive substances — to the point that the name “molly” no longer reliably describes what’s in the bag. Similarly, research analyzing EcstasyData submissions over 25 years found that the relationship between form (powder vs. pill) and purity is unreliable; both are routinely misrepresented (PMID 39437494).

The real distinction between forms: pills have a fixed geometry that makes dosing more predictable — once you know what’s in the tablet, at least you know the total. Powder requires accurate weighing. Neither form provides information about purity without testing.

What pressed pills commonly contain

Drug checking data from EcstasyData/DrugsData (1999–2023) and DanceSafe programs shows a shifting landscape of adulterants:

• Synthetic cathinones — methylone, pentylone, N-ethyl pentylone (ephylone): the dominant adulterant class of the past decade. Often produce effects initially resembling MDMA but with different duration, toxicity, and risk profile.
• Amphetamine and methamphetamine: produces stimulant effects but far longer duration, greater cardiovascular load, and higher addiction potential than MDMA.
• Caffeine: historically one of the most common cutting agents. Adds little direct harm but tells you the pill is being padded.
• Piperazines (BZP, mCPP): marketed as legal MDMA alternatives in the 2009–2013 period; associated with anxiety, seizures, and a miserable experience at high doses.
• DXM (dextromethorphan): common in early-2000s US pill market; dissociative with unpredictable effects at ecstasy doses.
• PMA/PMMA: rare but high-risk — slower onset than MDMA (meaning users redose, thinking it hasn’t worked) combined with a narrow therapeutic window. Associated with multiple deaths.
• Fentanyl: detected in some MDMA samples, though less common than in opioid or cocaine markets. Still tested in some samples from drug checking services (PMID 37826988 documents fentanyl’s broader spread into the stimulant supply).
• Nothing active at all: some pills contain only inactive fillers.

199 unique adulterants were detected in alleged MDMA samples between 1999 and 2023. No single list covers everything in circulation.

Why N-ethyl pentylone is the most dangerous adulterant right now

N-ethyl pentylone (also called ephylone) is a synthetic cathinone that has been found in pressed MDMA tablets across the US, UK, Australia, and South Africa. It is significantly more potent than MDMA by weight, meaning a pill pressed at a standard ecstasy dose contains a large relative dose of N-ethyl pentylone.

The danger is in how it deceives:

1. Initial effects partially resemble MDMA — enough that many users don’t realize they’ve taken something else.
2. The empathogenic “peak” fades faster than MDMA’s. Users feel like the drug wore off.
3. The stimulant component does not fade. N-ethyl pentylone’s stimulant effects are prolonged — community reports document inability to sleep for 36 hours or more, even without redosing. With redosing, the timeline extends further.
4. Users redose because they think the first pill stopped working. Each additional dose increases the stimulant load without increasing the empathogenic effect they were seeking.

The result is stimulant toxicity: tachycardia, hyperthermia, agitation, paranoia, hallucinations, and in severe cases, death. Multiple fatalities linked to N-ethyl pentylone have been documented in forensic toxicology case reports.

Critically: N-ethyl pentylone does NOT produce the same reagent test results as MDMA. Testing your pills with a Marquis reagent will catch this substitution.

Variable dosing in pills: why you can’t eyeball it

MDMA content in pressed tablets varies enormously. Morefield et al. (Addiction, 2011; PMID 21320226) analyzed pill content and resulting plasma concentrations and confirmed that the relationship between pill appearance and MDMA dose is unreliable. Pills that look identical — same logo, same color, same size — can contain dramatically different amounts.

European pill monitoring data shows the trend toward higher doses: average MDMA content in tested pills has climbed, with some tablets exceeding 300 mg. A 300 mg pill is two to three times a moderate recreational dose. Taking one tablet assuming it contains a standard dose, then redosing because you feel nothing after 45 minutes, is how people end up in emergency departments.

Half a pill, wait 90 minutes is the minimum precaution with any pill you can’t verify by lab test.

The “molly is purer” myth

The idea that powder form equals higher purity persists because it sounds intuitive — no pressing process, no additives needed to hold a tablet shape. In practice, the opposite can be true:

• Powder is easier to cut: any white or off-white powder can be mixed in without detection by the naked eye
• Pills require a pill press and mold — a higher-effort operation that some suppliers use as a quality signal for their product
• DanceSafe’s analysis of their own drug checking data found no evidence that powder MDMA is less likely to be adulterated than pressed pills
• Saleemi et al. (Journal of Psychopharmacology, 2017; PMID 28693371) found that products sold as “molly” at raves contained a range of non-MDMA substances at similar rates to ecstasy pills

Neither form is safer by default. The form tells you nothing. Testing tells you something.

How to test pressed pills before use

Pills have one testing advantage over powder: the surface area makes color reactions easier to read. Scrape a small amount (match-head size) off the pill for each test — don’t use powder from inside a capsule alone if you can avoid it.

Marquis reagent — the primary test

Add 1–2 drops to a small scraping on a white ceramic surface. Watch for 30–60 seconds.

• MDMA: purple → black
• Methamphetamine/amphetamine: orange → brown
• No MDMA present: orange, yellow, or no reaction

If Marquis does not turn purple to black, stop there. Do not use the substance.

Simon’s reagent — distinguishes MDMA from MDA

• MDMA: turns blue
• MDA: no color change

MDA has a longer duration than MDMA and different pharmacology. Knowing which one you have matters for dosing.

Mecke reagent — additional confirmation

• MDMA: blue-green to black
• Catches some cathinones that Marquis may miss in mixed samples

Fentanyl test strips

Dissolve a small pill fragment in water — use at least 5–10 mL (1–2 teaspoons) to avoid a false positive with MDMA. Dip the strip for 15 seconds, wait 2–5 minutes.

• Two lines = fentanyl not detected
• One line = fentanyl detected — do not use

All of these are available in DanceSafe’s complete 9-kit set. For step-by-step testing instructions see our test kit guide.

If you’re going to use

Testing is step one — it narrows the field but doesn’t guarantee purity or dose. Once you have a result:

• Harm reduction guidelines suggest starting with half a pill. Wait a full 90 minutes before deciding whether to take more. MDMA takes longer to peak than people expect, especially on a full stomach.
• If effects feel “off” — too much stimulation, not enough warmth, effects fading fast then nothing: this is consistent with a cathinone substitution. Do not redose. The stimulant effects may persist for hours.
• Don’t mix with alcohol or other substances — especially relevant if testing was inconclusive. See our interaction checker for specific combinations.
• Stay hydrated but don’t overdrink — 250–500 mL of water per hour if dancing; less if not active.
• Have naloxone accessible even at MDMA-oriented events. Fentanyl contamination is rare in MDMA specifically, but the consequence of encountering it without naloxone nearby is severe.
• Tell someone what you took. If things go wrong, that information matters.

For comprehensive MDMA harm reduction — dosing, supplements, dangerous interactions, and comedown — see our MDMA harm reduction guide.

Sources: PMID 39437494 — Misrepresentation of MDMA in the United States, 1999–2023 | PMID 37826988 — Fentanyl in community drug checking samples | PMID 28693371 — Saleemi et al., Who is “Molly”? | PMID 21320226 — Morefield et al., pill content and plasma concentrations | PMC5578728 — Palamar et al., There’s Something About Molly | DanceSafe drug checking | DrugsData.org